S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7233 −0.26%
CLOSED · 16:55 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead

OCUL

OCULAR THERAPEUTIX, INC
NASDAQ · HEALTH CARE · PHARMACEUTICAL PREPARATIONS
10.64
+0.00 +0.00%
USD · close Sep 4

Insider trading

SEC FORM 4 · OPEN-MARKET ONLY
−$333K
Net, 90 days
0 / 5
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
TradedFiledInsiderTypeSharesPriceValue
Aug 31Sep 2Notman Donald · Chief Operating OfficerSell1,099$10.24$11K
Aug 24Aug 26Nayak Sanjay · Chief Strategy OfficerSell1,897$10.78$20K
Aug 24Aug 26Kaiser Peter · Chief Development OfficerSell3,035$10.77$33K
Aug 24Aug 26Heier Jeffrey S. · Chief Scientific OfficerSell3,296$10.78$36K
Aug 24Aug 26Dugel Pravin · See RemarksSell21,649$10.77$233K

Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.

Watch OCUL. Know when insiders buy.
One email the day a filing lands. Free.